ethinyl estradiol has been researched along with ethinylestradiol-3-sulfate in 46 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 29 (63.04) | 18.7374 |
| 1990's | 2 (4.35) | 18.2507 |
| 2000's | 5 (10.87) | 29.6817 |
| 2010's | 7 (15.22) | 24.3611 |
| 2020's | 3 (6.52) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Böhm, WD; Geissler, W; Gorski, J; Illig, HD; Koch, R | 1 |
| Göretzlehner, G; Leminski, A; Ulrich, U; Weber, A; Wodrig, W | 1 |
| Göretzlehner, G; Lembke, J; Leminski, A; Weber, A; Wodrig, W | 1 |
| Bär, CM; Dörner, G; Fröhlich, G; Schnorr, D; Stahl, F | 1 |
| Dörner, G; Guddat, HM; Rohde, W; Schnorr, D; Stahl, F | 2 |
| Fiedler, R; Klebingat, KJ; Lorenz, G; Panzig, E; Steinhauser, I | 1 |
| Guddat, HM; Schnorr, D; Zemke, F | 1 |
| Dörner, G; Guddat, HM; Rhode, W; Schnorr, D; Stahl, F | 1 |
| Dörner, G; Rohde, W; Schnorr, D; Stahl, F | 2 |
| Drawz, B; Drawz, G; Hoffmann, L; Russbüldt, R | 1 |
| Schott, H; Zade, W | 1 |
| Sladczyk, E | 1 |
| Brachmann, K; Göretzlehner, G; Männchen, E; Nikschick, S | 2 |
| Kunkel, S; Meissner, J; Rudolf, K; Rüting, M | 1 |
| Blödow, K; Kunkel, S; Rudolf, K | 1 |
| Kunkel, S; Rudolf, K; Woltanski, KP | 1 |
| Kunkel, S; Rudolf, H; Rudolf, K | 1 |
| Görlich, M; Gürtler, R | 1 |
| Carol, W; Klinger, G; Lauterbach, H | 1 |
| Kindt, J; Retzke, U; Scheunert, EU | 1 |
| Chemnitius, KH; Machnik, G; Niekrenz, H | 1 |
| Chemnitius, KH; Claussen, C; Huebler, D; Naumann, A | 1 |
| Castracane, VD; Goldzieher, JW; Moore, PH; Newburger, J; Williams, MC | 1 |
| Bodek, B; Gürtler, R; Morack, G; Tanneberger, S | 1 |
| Claussen, C; Klinger, G; Schröder, S | 1 |
| Fotherby, K; Reed, MJ | 1 |
| Carver, JM; Lundeen, SG; McKean, ML; Winneker, RC | 1 |
| Benet, LZ; Bornheim, LM; Correia, MA; Hanstein, WG; Jäger, W; Mahnke, A; Xue, L | 1 |
| Braun, MP; Chu, XY; Evans, DC; Evers, R; Huskey, SE; Sarkadi, B | 1 |
| Kagayama, A; Niwa, T; Ohno, Y; Shiraga, T | 1 |
| Bosveld, AT; Rouhani Rankouhi, T; Sanderson, JT; van den Berg, M; van Holsteijn, I; van Kooten, P | 1 |
| Hayashi, M; Kawashima, K; Mizuma, T; Sakaguchi, S; Sakai, S | 1 |
| Busler, D; Chen, C; Han, YH; Hong, Y; Rodrigues, AD; Tian, Y | 2 |
| Miyazawa, Y; Nakano, K; Nakata, S; Sasaki, Y; Takahashi, H | 1 |
| Day, JS; Hillgren, KM; Phillips, DL; Zamek-Gliszczynski, MJ | 1 |
| Chen, S; Fu, Z; Jin, Y; Li, Y; Lin, X; Miao, W; Pan, Q; Shen, H; Wu, T | 1 |
| Berman, J; Burlington, DB; Chaudry, IH; Grudzinskas, C; Hubbard, W; Keith, J; Miller, M; Peck, C; Scott, C | 1 |
| Berman, J; Chaudry, IH; Hubbard, W; Keith, J; Miller, M; Peck, C; Scott, C | 1 |
| Chaudry, IH; Hubbard, WJ; Yang, S | 1 |
| Abdou, H; Berman, J; Chaudry, IH; Edwards, J; Elansary, N; Gopalakrishnan, M; Hubbard, WJ; Lang, E; Morrison, JJ; Patel, N; Richmond, MJ; Scalea, TM | 1 |
| Cap, AP; Le, TD; Martini, WZ; Xia, H | 1 |
4 trial(s) available for ethinyl estradiol and ethinylestradiol-3-sulfate
| Article | Year |
|---|---|
[Clinical value of ethinyl estradiol sulfonate (Turisteron)--long-term results of a randomized compound study].
Topics: Aged; Clinical Trials as Topic; Combined Modality Therapy; Ethinyl Estradiol; Follow-Up Studies; Humans; Male; Neoplasm Staging; Palliative Care; Prostatic Neoplasms; Random Allocation | 1987 |
[Cellular immunity in prostatic cancer modified by Cytonal, Estrazyt and Turisteron].
Topics: Aged; Antineoplastic Agents; Clinical Trials as Topic; Combined Modality Therapy; Diethylstilbestrol; Estramustine; Ethinyl Estradiol; Humans; Immunity, Cellular; Macrophages; Male; Middle Aged; Nitrogen Mustard Compounds; Prostatic Neoplasms; Random Allocation | 1987 |
[Initial results of a phase IV multicenter clinical trial of Turisteron in the treatment of prostate cancer].
Topics: Adult; Aged; Aged, 80 and over; Clinical Trials as Topic; Combined Modality Therapy; Ethinyl Estradiol; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Staging; Prostatic Neoplasms | 1987 |
Assessment of ethynylestradiol-3-sulfate on coagulation, metabolism, and survival in pigs with traumatic hemorrhage.
Topics: Animals; Blood Coagulation; Ethinyl Estradiol; Hemorrhage; Oxygen; Resuscitation; Shock, Hemorrhagic; Swine | 2023 |
42 other study(ies) available for ethinyl estradiol and ethinylestradiol-3-sulfate
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Pituitary response in the doubled GnRH-TRH test on the 5th day post partum or post abortum after ablactation by oral means of ethinylestradiol sulfonate.
Topics: Abortion, Spontaneous; Administration, Oral; Adolescent; Adult; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Hypothalamo-Hypophyseal System; Lactation; Luteinizing Hormone; Pituitary Hormone-Releasing Hormones; Postpartum Period; Pregnancy; Prolactin; Thyrotropin; Thyrotropin-Releasing Hormone | 1989 |
[The double GnRH-TRH test following control of lactation with ethinyl estradiol sulfonate after abortion, early and term labor].
Topics: Abortion, Spontaneous; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Infant, Newborn; Lactation; Obstetric Labor, Premature; Pregnancy; Prolactin; Thyrotropin; Thyrotropin-Releasing Hormone | 1989 |
Suppression of plasma androgen levels with a combination therapy of depot-estrogen (Turisteron) and Dexamethasone in patients with prostatic cancer.
Topics: Aged; Aged, 80 and over; Androgens; Dexamethasone; Drug Therapy, Combination; Ethinyl Estradiol; Humans; Male; Middle Aged; Prostatic Neoplasms | 1989 |
[Conservative therapy of prostate cancer using Turisteron].
Topics: Aged; Aged, 80 and over; Combined Modality Therapy; Ethinyl Estradiol; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Male; Middle Aged; Neoplasm Staging; Prostatic Neoplasms; Testosterone | 1987 |
[Behavior of LH, FSH, total testosterone, free testosterone and SHBG serum levels in the therapy of prostatic cancer with Turisteron (ethinyl estradiol sulfonate)].
Topics: Ethinyl Estradiol; Follicle Stimulating Hormone; Follow-Up Studies; Gonadal Steroid Hormones; Humans; Luteinizing Hormone; Male; Prostatic Neoplasms; Sex Hormone-Binding Globulin; Testosterone | 1987 |
[Clinical study of ethinyl estradiol sulfonate in conservative therapy of prostate cancer].
Topics: Adenocarcinoma; Aged; Androgen Antagonists; Combined Modality Therapy; Drug Implants; Ethinyl Estradiol; Humans; Luteinizing Hormone; Male; Middle Aged; Orchiectomy; Prostatic Neoplasms; Sex Hormone-Binding Globulin; Testosterone | 1987 |
[Inhibition of the free, biologically active testosterone level by Turisteron in patients with prostate cancer].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Combined Modality Therapy; Delayed-Action Preparations; Diethylstilbestrol; Ethinyl Estradiol; Humans; Luteinizing Hormone; Male; Middle Aged; Prostatic Neoplasms; Sex Hormone-Binding Globulin; Testosterone | 1987 |
[Experiences in the treatment of advanced prostatic cancer using Turisteron with special reference to cardiovascular complications].
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carcinoma; Cardiovascular Diseases; Ethinyl Estradiol; Humans; Male; Middle Aged; Prostatic Neoplasms; Risk | 1987 |
[Liver damage in hormone therapy of prostate cancer].
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Chemical and Drug Induced Liver Injury; Combined Modality Therapy; Diethylstilbestrol; Ethinyl Estradiol; Humans; Liver Function Tests; Male; Middle Aged; Prostatic Neoplasms | 1987 |
[Clinical experience using Turisteron in the treatment of prostatic cancer].
Topics: Aged; Drug Resistance; Ethinyl Estradiol; Humans; Male; Prognosis; Prostatic Neoplasms | 1987 |
The influence of a sequential-type oral contraceptive with ethinylestradiol-sulfonate soft gelatin capsules and norethisterone acetate on carbohydrate metabolism during the first twelve months.
Topics: Adult; Blood Glucose; Carbohydrate Metabolism; Contraceptives, Oral; Contraceptives, Oral, Sequential; Delayed-Action Preparations; Ethinyl Estradiol; Female; Humans; Insulin; Norethindrone; Norethindrone Acetate; Time Factors | 1985 |
Successful treatment of prostatic cancer with the orally active depot estrogen ethinylestradiol sulfonate (Turisteron).
Topics: Aged; Delayed-Action Preparations; Ethinyl Estradiol; Gonadotropin-Releasing Hormone; Humans; Male; Middle Aged; Orchiectomy; Prostatic Neoplasms; Testosterone | 1985 |
[Effect of ethinyl estradiol sulfonate/norethisterone acetate on gonadotropin secretion in pubertal girls].
Topics: Adolescent; Body Height; Child; Drug Therapy, Combination; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Norethindrone; Norethindrone Acetate; Pituitary Hormone-Releasing Hormones; Puberty; Radioimmunoassay | 1985 |
[Effect of ethinyl estradiol sulfonate/norethisterone acetate on PRI secretion in pubertal girls].
Topics: Adolescent; Body Height; Child; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Norethindrone; Norethindrone Acetate; Prolactin; Puberty; Radioimmunoassay; Thyrotropin-Releasing Hormone | 1985 |
[Effect of ethinyl estradiol sulfonate/norethisterone acetate on HGH secretion in pubertal girls].
Topics: Adolescent; Adult; Arginine; Body Height; Chorionic Gonadotropin; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Norethindrone; Norethindrone Acetate; Pituitary Hormone-Releasing Hormones; Puberty; Radioimmunoassay; Thyrotropin-Releasing Hormone | 1985 |
[Effect of ethinyl estradiol sulfonate/norethisterone acetate on TSH, T4, TBC and the FT4 index in pubertal girls].
Topics: Adolescent; Arginine; Body Height; Child; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Norethindrone; Norethindrone Acetate; Pituitary Hormone-Releasing Hormones; Puberty; Thyroid Hormones; Thyrotropin; Thyrotropin-Releasing Hormone; Thyroxine; Thyroxine-Binding Proteins | 1985 |
Clinical relevance of steroid hormone receptors.
Topics: Adrenal Cortex Hormones; Breast Neoplasms; Ethinyl Estradiol; Female; Humans; Prognosis; Receptors, Estradiol; Receptors, Progesterone; Receptors, Steroid; Tamoxifen | 1985 |
[Effect of sequential preparation with ethinyl estradiol sulfonate soft gelatin capsules and norethindrone acetate on carbohydrate metabolism].
Topics: Adult; Blood Glucose; Capsules; Drug Administration Schedule; Ethinyl Estradiol; Female; Gelatin; Glucose Tolerance Test; Humans; Insulin; Norethindrone; Norethindrone Acetate; Pharmaceutical Vehicles | 1984 |
[Testing of the steroid-related suppressive effect on the hypothalamo-hypophyseal system using twofold stimulation].
Topics: Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Follicle Stimulating Hormone; Humans; Hypothalamo-Hypophyseal System; Luteinizing Hormone; Menstruation; Norethindrone; Norgestrel; Pituitary Hormone-Releasing Hormones; Prolactin; Thyrotropin-Releasing Hormone | 1984 |
[Effect of ethinyl estradiol sulfonate on the urethral epithelium after bilateral oophorectomy].
Topics: Adult; Castration; Drug Evaluation; Epithelial Cells; Epithelium; Ethinyl Estradiol; Female; Humans; Male; Middle Aged; Postoperative Period; Time Factors; Urethra | 1984 |
Liver neoplasms after long-term steroid application in rats.
Topics: Adrenal Gland Neoplasms; Animals; Ethinyl Estradiol; Female; Liver Neoplasms; Male; Mammary Neoplasms, Experimental; Pituitary Neoplasms; Precancerous Conditions; Rats; Rats, Inbred Strains; Time Factors | 1983 |
Pharmacokinetics of ethynyl estradiolsulfonate in minipigs.
Topics: Administration, Oral; Animals; Ethinyl Estradiol; Injections, Intravenous; Kinetics; Male; Swine; Swine, Miniature | 1984 |
The pharmacokinetics and metabolism of ethinyl estradiol and its three sulfates in the baboon.
Topics: Administration, Oral; Animals; Castration; Ethinyl Estradiol; Female; Half-Life; Injections, Intravenous; Kinetics; Models, Biological; Papio; Radioimmunoassay | 1983 |
[Clinical experience with the depot estrogen Turisteron in the treatment of metastatic breast cancer (author's transl)].
Topics: Aged; Breast Neoplasms; Delayed-Action Preparations; Drug Evaluation; Ethinyl Estradiol; Female; Humans; Middle Aged; Prognosis | 1982 |
[Excretion of ethinyloestradiol sulfonate in the human milk (author's transl)].
Topics: Chromatography, Thin Layer; Ethinyl Estradiol; Female; Humans; Lactation; Milk, Human; Pregnancy | 1981 |
Interaction of ethynyloestradiol sulphate with plasma proteins.
Topics: Binding Sites; Binding, Competitive; Blood Proteins; Chemical Phenomena; Chemistry; Estrone; Ethinyl Estradiol; Female; Humans; Male; Protein Binding; Serum Albumin | 1980 |
Characterization of the ovariectomized rat model for the evaluation of estrogen effects on plasma cholesterol levels.
Topics: Animals; Cholesterol; Dexamethasone; Disease Models, Animal; Estradiol; Estrogen Antagonists; Estrogens; Ethinyl Estradiol; Female; Fulvestrant; Lipids; Ovariectomy; Piperidines; Progesterone; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Tamoxifen; Uterus | 1997 |
Ethynylestradiol-mediated induction of hepatic CYP3A9 in female rats: implication for cyclosporine metabolism.
Topics: Actins; Animals; Aryl Hydrocarbon Hydroxylases; Cyclosporine; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Enzyme Induction; Ethinyl Estradiol; Female; Glyceraldehyde-3-Phosphate Dehydrogenases; Immunosuppressive Agents; Liver; Male; Microsomes, Liver; Oxidoreductases, N-Demethylating; Rats | 1999 |
Transport of ethinylestradiol glucuronide and ethinylestradiol sulfate by the multidrug resistance proteins MRP1, MRP2, and MRP3.
Topics: Animals; Biological Transport; Cell Line; Cell Membrane; Drug Interactions; Estradiol; Ethinyl Estradiol; Insecta; Membrane Transport Proteins; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Tritium | 2004 |
Interindividual variability in 2-hydroxylation, 3-sulfation, and 3-glucuronidation of ethynylestradiol in human liver.
Topics: Adolescent; Adult; Aged; Ethinyl Estradiol; Female; Glucuronides; Humans; Hydroxylation; Liver; Male; Middle Aged; Sulfates | 2004 |
Effects of environmental and natural estrogens on vitellogenin production in hepatocytes of the brown frog (Rana temporaria).
Topics: Animals; Benzhydryl Compounds; Diethylstilbestrol; Estradiol; Estrogens; Estrone; Ethinyl Estradiol; Female; Hepatocytes; Male; Methoxychlor; Phenols; Rana temporaria; Vitellogenesis; Vitellogenins | 2005 |
Differentiation of organ availability by sequential and simultaneous analyses: intestinal conjugative metabolism impacts on intestinal availability in humans.
Topics: Albuterol; Biological Availability; Ethinyl Estradiol; Models, Biological; Organ Specificity; Pharmaceutical Preparations; Terbutaline; Tissue Distribution | 2005 |
Transporter studies with the 3-O-sulfate conjugate of 17alpha-ethinylestradiol: assessment of human liver drug transporters.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport, Active; Carrier Proteins; Cell Line, Transformed; Ethinyl Estradiol; Hepatocytes; Humans; Kinetics; Liver; Liver-Specific Organic Anion Transporter 1; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Organic Anion Transporters; Organic Anion Transporters, Sodium-Dependent; Symporters; Transfection | 2010 |
Transporter studies with the 3-O-sulfate conjugate of 17alpha-ethinylestradiol: assessment of human kidney drug transporters.
Topics: Animals; Biological Transport; Carrier Proteins; Cell Line, Transformed; Dogs; Ethinyl Estradiol; Humans; Insecta; Kidney; Kinetics; Multidrug Resistance-Associated Proteins; Organic Anion Transport Protein 1; Organic Anion Transporters, Sodium-Independent; Organic Cation Transport Proteins; Organic Cation Transporter 2; Substrate Specificity; Transfection | 2010 |
[Prognostic factors for estrogen therapy of relapsed prostate cancer after maximal androgen blockade (MAB)].
Topics: Aged; Androgen Antagonists; Combined Modality Therapy; Diethylstilbestrol; Drug Therapy, Combination; Estramustine; Estrogens; Ethinyl Estradiol; Humans; Kaplan-Meier Estimate; Male; Neoplasm Recurrence, Local; Prognosis; Proportional Hazards Models; Prostatic Neoplasms; Survival Rate; Time Factors | 2010 |
Efflux transport is an important determinant of ethinylestradiol glucuronide and ethinylestradiol sulfate pharmacokinetics.
Topics: Administration, Oral; Animals; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biliary Tract; Biological Transport; Cell Membrane; Estradiol; Ethinyl Estradiol; Half-Life; Intestinal Mucosa; Liver; Male; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Rats; Rats, Wistar | 2011 |
Chronic exposure of mice to environmental endocrine-disrupting chemicals disturbs their energy metabolism.
Topics: Adipose Tissue; Animals; Atrazine; Body Weight; Cholesterol; Endocrine Disruptors; Energy Metabolism; Ethinyl Estradiol; Fatty Acids, Nonesterified; Liver; Male; Mice; Mice, Inbred C57BL; Pyrethrins; Random Allocation; Real-Time Polymerase Chain Reaction; RNA, Messenger; Triglycerides | 2014 |
Efficacy of 17α-ethynylestradiol-3-sulfate for severe hemorrhage in minipigs in the absence of fluid resuscitation.
Topics: Animals; Blood Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Ethinyl Estradiol; Fluid Therapy; Hemorrhage; Injections, Intravenous; Male; Resuscitation; Severity of Illness Index; Survival Rate; Swine; Swine, Miniature; Treatment Outcome | 2014 |
17α-Ethynylestradiol-3-sulfate treatment of severe blood loss in rats.
Topics: Animals; Blood Glucose; Blood Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Ethinyl Estradiol; Hemorrhage; Hydrogen-Ion Concentration; Kaplan-Meier Estimate; Lactic Acid; Male; Rats, Sprague-Dawley; Sodium Chloride; Survival Rate; Trauma Severity Indices | 2015 |
Ethinyl estradiol sulfate acts without fluid resuscitation through estrogen receptors to rapidly protect the cardiovascular system from severe hemorrhage.
Topics: Animals; Apoptosis; Cardiovascular System; Disease Models, Animal; Dose-Response Relationship, Drug; Estrogens; Ethinyl Estradiol; Inflammation; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Rats; Receptors, Estrogen; Shock, Hemorrhagic; Signal Transduction; Swine; Treatment Outcome | 2021 |
An estrogen (17α-ethinyl estradiol-3-sulfate) reduces mortality in a swine model of multiple injuries and hemorrhagic shock.
Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Monitoring; Estrogens; Ethinyl Estradiol; Male; Multiple Trauma; Myocardial Contraction; Shock, Hemorrhagic; Survival Analysis; Swine; Treatment Outcome | 2022 |